Physician

Kevin Arash Reinard, M.D.

According to 2025 Medicare claims, Kevin Reinard, M.D. (NPI: 1588825772) practices neurosurgery in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is PROMEDICA CENTRAL PHYSICIANS (NPI: 1043270150; TIN: 341881137) and primary practice location at 43606-3895. Reinard is affiliated with the ProMedica Health Network, Inc. (ACO ID: A3016), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Reinard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 372 traditional Medicare patients, billed 933 HCPCS/CPT codes, and received $382,775 in Medicare payments. The top billing code was 63047 (Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment). Part D data shows 1,231 prescription claims across 335 beneficiaries totaling $11,827 in drug costs, led by Celecoxib (Celecoxib). 2019 DME data shows 24 claims. Open Payments data shows 3 records totaling $153. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,635 to $382,775. Similarly, Part D prescription costs have risen steadily, from $888 to $11,827. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	73	176	$16,635
2016	181	393	$117,897
2017	393	966	$317,539
2018	440	952	$265,771
2019	382	810	$225,701
2020	395	799	$205,020
2021	400	933	$266,524
2022	346	885	$311,850
2023	367	912	$329,109
2024	372	933	$382,775

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	18	$888
2016	44	89	$2,266
2017	176	460	$7,944
2018	249	675	$8,712
2019	224	581	$6,828
2020	198	523	$6,540
2021	205	577	$9,378
2022	216	637	$12,430
2023	273	883	$12,991
2024	335	1,231	$11,827

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	12	12	$1,279
2018	N/R	N/R	N/R
2019	12	24	$12,515
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
63047	Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment	54	54	$766
63048	Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment	51	94	$169
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	74	74	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	82	90	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	74	87	$70

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Celecoxib	Celecoxib	88	2,758	$2,868
Gabapentin	Gabapentin	236	8,308	$2,600
Levetiracetam	Levetiracetam	50	1,650	$1,154
Methylprednisolone	Methylprednisolone	166	996	$953
Tizanidine Hcl	Tizanidine Hcl	213	2,672	$794

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$153	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kevin Arash Reinard, M.D.?

Tedicare shows public-source Medicare data for Kevin Arash Reinard, M.D. (NPI 1588825772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Arash Reinard, M.D. have ACO affiliation data?

Kevin Arash Reinard, M.D. is shown with ACO affiliation data for ProMedica Health Network, Inc. (MSSP, ACO ID A3016), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Kevin Arash Reinard, M.D.?

Kevin Arash Reinard, M.D. is linked to PROMEDICA CENTRAL PHYSICIANS (billing NPI 1043270150) in the available physician profile data.

Does Kevin Arash Reinard, M.D. have Open Payments data?

Kevin Arash Reinard, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.